Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 860642-69-9
2. Vpd-737
3. Serlopitant [usan]
4. Mk-0594
5. Chembl447955
6. 3-((3ar,4r,5s,7as)-5-((r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-4-(4-fluorophenyl)hexahydro-1h-isoindol-2(3h)-yl)cyclopent-2-enone
7. Serlopitant (usan)
8. 277v92k32b
9. 3-((3ar,4r,5s,7as)-5-((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-4-(4 Fluorophenyl)octahydro-2h-isoindol-2-yl)cyclopent-2-en-1-one
10. 3-[(3ar,4r,5s,7as)-5-[(1r)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-4-(4-fluorophenyl)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]cyclopent-2-en-1-one
11. Serlopitant [usan:inn]
12. Unii-277v92k32b
13. Vpd 737
14. Serlopitant [inn]
15. Serlopitant [who-dd]
16. Gtpl9280
17. Schembl3183159
18. C29h28f7no2
19. Dtxsid701006599
20. Bdbm50277511
21. Mfcd18782619
22. Compound 17 (jiang Et Al. 2009)
23. Db12973
24. Vpd-737; Mk-0594
25. Hy-12114
26. Cs-0003087
27. D09378
28. Q21098912
29. 2-cyclopenten-1-one, 3-((3ar,4r,5s,7as)-5-((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-4-(4-fluorophenyl)octahydro-2h-isoindol-2-yl)-
30. 3-((3ar,4r,5s,7as)-5-((r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-4-(4-fluorophenyl)octahydro-2h-isoindol-2-yl)cyclopent-2-en-1-one
31. 3-[(3ar,4r,5s,7as)-5-{(1r)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)-octahydro-2h-isoindol-2-yl]cyclopent-2-en-1-one
32. 3-[(3ar,4r,5s,7as)-5-{(1r)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)octahydro-1h-isoindol-2-yl]cyclopent-2-en-1-one
33. 3-[5-{1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)octahydro-2h-isoindol-2-yl]cyclopent-2-en-1-one
| Molecular Weight | 555.5 g/mol |
|---|---|
| Molecular Formula | C29H28F7NO2 |
| XLogP3 | 6.6 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 5 |
| Exact Mass | 555.20082627 g/mol |
| Monoisotopic Mass | 555.20082627 g/mol |
| Topological Polar Surface Area | 29.5 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 888 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of prurigo nodularis
Neurokinin-1 Receptor Antagonists
Compounds that inhibit or block the activity of NEUROKININ-1 RECEPTORS. (See all compounds classified as Neurokinin-1 Receptor Antagonists.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Serlopitant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Serlopitant, including repackagers and relabelers. The FDA regulates Serlopitant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Serlopitant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Serlopitant supplier is an individual or a company that provides Serlopitant active pharmaceutical ingredient (API) or Serlopitant finished formulations upon request. The Serlopitant suppliers may include Serlopitant API manufacturers, exporters, distributors and traders.
Serlopitant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Serlopitant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Serlopitant GMP manufacturer or Serlopitant GMP API supplier for your needs.
A Serlopitant CoA (Certificate of Analysis) is a formal document that attests to Serlopitant's compliance with Serlopitant specifications and serves as a tool for batch-level quality control.
Serlopitant CoA mostly includes findings from lab analyses of a specific batch. For each Serlopitant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Serlopitant may be tested according to a variety of international standards, such as European Pharmacopoeia (Serlopitant EP), Serlopitant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Serlopitant USP).
LOOKING FOR A SUPPLIER?
